115 related articles for article (PubMed ID: 17224994)
21. An essential nuclear protein in trypanosomes is a component of mRNA transcription/export pathway.
Serpeloni M; Moraes CB; Muniz JR; Motta MC; Ramos AS; Kessler RL; Inoue AH; daRocha WD; Yamada-Ogatta SF; Fragoso SP; Goldenberg S; Freitas-Junior LH; Avila AR
PLoS One; 2011; 6(6):e20730. PubMed ID: 21687672
[TBL] [Abstract][Full Text] [Related]
22. Natural sesquiterpene lactones induce programmed cell death in Trypanosoma cruzi: a new therapeutic target?
Jimenez V; Kemmerling U; Paredes R; Maya JD; Sosa MA; Galanti N
Phytomedicine; 2014 Sep; 21(11):1411-8. PubMed ID: 25022207
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and antitrypanosomal activity of some nitrofurazone 1,2,4-triazolic bioisosteric analogues.
Silva FT; Franco CH; Favaro DC; Freitas-Junior LH; Moraes CB; Ferreira EI
Eur J Med Chem; 2016 Oct; 121():553-560. PubMed ID: 27318979
[TBL] [Abstract][Full Text] [Related]
24. Morpholino antisense oligo inhibits trans-splicing of pre-inositol 1,4,5-trisphosphate receptor mRNA of Trypanosoma cruzi and suppresses parasite growth and infectivity.
Hashimoto M; Nara T; Mita T; Mikoshiba K
Parasitol Int; 2016 Jun; 65(3):175-9. PubMed ID: 26680159
[TBL] [Abstract][Full Text] [Related]
25. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
26. In vitro drug susceptibility of two strains of the wildlife trypanosome, Trypanosoma copemani: A comparison with Trypanosoma cruzi.
Botero A; Keatley S; Peacock C; Thompson RC
Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):34-41. PubMed ID: 28040568
[TBL] [Abstract][Full Text] [Related]
27. The transcription promoter of the spliced leader gene from Trypanosoma cruzi.
Nunes LR; Carvalho MR; Shakarian AM; Buck GA
Gene; 1997 Apr; 188(2):157-68. PubMed ID: 9133587
[TBL] [Abstract][Full Text] [Related]
28. ABCG-like transporter of Trypanosoma cruzi involved in benznidazole resistance: gene polymorphisms disclose inter-strain intragenic recombination in hybrid isolates.
Franco J; Ferreira RC; Ienne S; Zingales B
Infect Genet Evol; 2015 Apr; 31():198-208. PubMed ID: 25660041
[TBL] [Abstract][Full Text] [Related]
29. Short leader sequences may be transferred from small RNAs to pre-mature mRNAs by trans-splicing in Euglena.
Tessier LH; Keller M; Chan RL; Fournier R; Weil JH; Imbault P
EMBO J; 1991 Sep; 10(9):2621-5. PubMed ID: 1868836
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a gene encoding alcohol dehydrogenase in benznidazole-susceptible and -resistant populations of Trypanosoma cruzi.
Campos FM; Liarte DB; Mortara RA; Romanha AJ; Murta SM
Acta Trop; 2009 Jul; 111(1):56-63. PubMed ID: 19426664
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo antiparasitic activity of Physalis angulata L. concentrated ethanolic extract against Trypanosoma cruzi.
Meira CS; Guimarães ET; Dos Santos JA; Moreira DR; Nogueira RC; Tomassini TC; Ribeiro IM; de Souza CV; Ribeiro Dos Santos R; Soares MB
Phytomedicine; 2015 Oct; 22(11):969-74. PubMed ID: 26407938
[TBL] [Abstract][Full Text] [Related]
32. mRNA splicing in trypanosomes.
Preußer C; Jaé N; Bindereif A
Int J Med Microbiol; 2012 Oct; 302(4-5):221-4. PubMed ID: 22964417
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates.
Quebrada Palacio LP; González MN; Hernandez-Vasquez Y; Perrone AE; Parodi-Talice A; Bua J; Postan M
PLoS One; 2018; 13(9):e0203462. PubMed ID: 30183775
[TBL] [Abstract][Full Text] [Related]
34. Trypanosoma cruzi specific mRNA amplification by in vitro transcription improves parasite transcriptomics in host-parasite RNA mixtures.
Kessler RL; Pavoni DP; Krieger MA; Probst CM
BMC Genomics; 2017 Oct; 18(1):793. PubMed ID: 29037144
[TBL] [Abstract][Full Text] [Related]
35. Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi.
Ribeiro TS; Freire-de-Lima L; Previato JO; Mendonça-Previato L; Heise N; de Lima ME
Bioorg Med Chem Lett; 2004 Jul; 14(13):3555-8. PubMed ID: 15177472
[TBL] [Abstract][Full Text] [Related]
36. [The chemotherapy of Chagas disease].
Stoppani AO
Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
[TBL] [Abstract][Full Text] [Related]
37. Investigating the structure-activity relationships of N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds.
Palace-Berl F; Pasqualoto KFM; Zingales B; Moraes CB; Bury M; Franco CH; da Silva Neto AL; Murayama JS; Nunes SL; Silva MN; Tavares LC
Eur J Med Chem; 2018 Jan; 144():29-40. PubMed ID: 29247858
[TBL] [Abstract][Full Text] [Related]
38. Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease.
Moreno M; D'ávila DA; Silva MN; Galvão LM; Macedo AM; Chiari E; Gontijo ED; Zingales B
Mem Inst Oswaldo Cruz; 2010 Nov; 105(7):918-24. PubMed ID: 21120364
[TBL] [Abstract][Full Text] [Related]
39. Trans-splicing in protozoa and helminths.
Nilsen TW
Infect Agents Dis; 1992 Aug; 1(4):212-8. PubMed ID: 1365548
[TBL] [Abstract][Full Text] [Related]
40. Trypanocidal activity of 4 isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi.
Nogueda-Torres B; Rodríguez-Paez L; Ramírez IB; Ramírez CW
Rev Latinoam Microbiol; 2001; 43(1):1-6. PubMed ID: 17061565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
